GILD vs STEP · P/E 18, rev $29.44B vs rev $1.99B
Gilead Sciences Inc (GILD) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. STEP currently screens at market cap $5.78B.
Not investment advice. Open the GILD and STEP stock pages for the full models.
Not investment advice.